Track your nutrition and health goals
Comprehensive Metabolic Panel (CMP): What It Tests, Normal Ranges & What Results Mean
By Dr. Sumedha Verma | Medically Reviewed | Updated April 2026
If your doctor has ordered a comprehensive metabolic panel, or if you have seen the abbreviation CMP on your lab report, you may be wondering what exactly it measures and what the results tell you about your health.
This guide explains every test included in a CMP, what normal and abnormal results mean, and why this panel is particularly relevant for anyone managing or monitoring metabolic syndrome.
| Quick Answer: A comprehensive metabolic panel (CMP) is a group of 14 blood tests that provides a broad snapshot of your kidney function, liver function, electrolyte balance, blood sugar, and protein levels. It is one of the most commonly ordered blood panels in clinical medicine, used for routine health screening, monitoring of chronic conditions, and assessment of metabolic health. |
|---|
What Is a Comprehensive Metabolic Panel?
A comprehensive metabolic panel is a standardised blood test that measures 14 different substances in your blood. It is ordered as a single test but returns results for multiple organ systems simultaneously, making it an efficient and cost-effective way to assess overall metabolic health.
The CMP is typically performed on a blood sample drawn from a vein in your arm. Results are usually available within 24 hours, and sometimes within a few hours at hospital labs.
In India, the CMP may sometimes be ordered as a 'liver function test plus kidney function test plus blood sugar' combination, which broadly covers the same ground.
When Is a CMP Ordered?
Doctors order a comprehensive metabolic panel in a wide range of situations:
- Routine annual health check or preventive screening
- Initial evaluation of symptoms like fatigue, nausea, swelling, or unexplained weight loss
- Monitoring of known conditions such as diabetes, kidney disease, or liver disease
- Assessment of metabolic syndrome or cardiovascular risk
- Monitoring side effects of medications that affect the liver or kidneys (e.g., statins, metformin, NSAIDs)
- Before and after surgical procedures
- Follow-up after abnormal results on a previous blood test
What Tests Are Included in a Comprehensive Metabolic Panel?
The CMP includes 14 specific blood markers organised into four groups: blood sugar, kidney function, electrolytes and fluid balance, and liver function.
1. Blood Glucose (Blood Sugar)
Glucose is the primary fuel for the body's cells. The CMP measures fasting blood glucose, which is used to screen for and monitor diabetes and prediabetes. [1]
| Result | Fasting Glucose (mg/dL) | What It Means |
|---|---|---|
| Normal | 70 to 99 | No diabetes or prediabetes |
| Prediabetes | 100 to 125 | Impaired fasting glucose, lifestyle intervention needed |
| Diabetes | 126 or above (on two tests) | Diabetes diagnosis likely; further evaluation required |
2. Blood Urea Nitrogen (BUN)
BUN measures the amount of urea nitrogen in the blood, a waste product formed when protein is broken down. Elevated BUN can indicate reduced kidney function, dehydration, or a high-protein diet. Normal range: 7 to 20 mg/dL. [2]
3. Creatinine
Creatinine is a waste product generated by muscle metabolism and filtered by the kidneys. It is a more reliable marker of kidney function than BUN. Elevated creatinine signals reduced kidney filtration capacity. [2]
- Normal range (men): 0.74 to 1.35 mg/dL
- Normal range (women): 0.59 to 1.04 mg/dL
4. Estimated Glomerular Filtration Rate (eGFR)
eGFR is calculated from the creatinine value, age, sex, and race. It estimates how well the kidneys are filtering blood per minute. An eGFR below 60 mL/min/1.73m2 sustained for more than 3 months indicates chronic kidney disease (CKD). [2]
5-8. Electrolytes: Sodium, Potassium, Carbon Dioxide (CO2), and Chloride
These four tests assess electrolyte balance and acid-base status. Together, they provide information about hydration, kidney function, and how well the body is regulating its chemical environment.
- Sodium (Normal: 136 to 145 mEq/L): Regulates fluid balance and blood pressure. Abnormally low (hyponatraemia) or high (hypernatraemia) values can indicate serious conditions.
- Potassium (Normal: 3.5 to 5.0 mEq/L): Critical for heart and muscle function. Values outside this range carry cardiac risk.
- CO2/Bicarbonate (Normal: 23 to 29 mEq/L): Reflects the body's acid-base balance. Low values may suggest metabolic acidosis.
- Chloride (Normal: 96 to 106 mEq/L): Works alongside sodium and bicarbonate to maintain fluid and acid-base balance.
9. Calcium
Calcium levels in the blood reflect bone health, parathyroid gland function, and, in some cases, kidney disease or certain cancers. Normal range: 8.5 to 10.2 mg/dL. Abnormal calcium is uncommon in routine metabolic screening, but it is important to detect it early.
10. Total Protein
Measures the total amount of proteins (mainly albumin and globulins) in the blood. Low total protein can indicate liver disease, malnutrition, or kidney disease (protein loss in urine). Normal range: 6.3 to 8.2 g/dL.
11. Albumin
Albumin is the most abundant protein in the blood, produced by the liver. Low albumin is a sensitive marker of liver dysfunction, malnutrition, or chronic illness. Normal range: 3.5 to 5.0 g/dL.
12. Total Bilirubin
Bilirubin is produced when red blood cells break down. The liver processes and excretes it. Elevated bilirubin causes jaundice and indicates liver dysfunction or bile duct obstruction. Normal range: 0.1 to 1.2 mg/dL. [3]
13. Alkaline Phosphatase (ALP)
ALP is an enzyme found in the liver, bones, kidneys, and intestines. Elevated ALP can suggest liver disease, bile duct problems, or bone disorders. Normal range: 44 to 147 IU/L (varies by lab and age). [3]
14. Alanine Aminotransferase (ALT) and Aspartate Aminotransferase (AST)
ALT and AST are liver enzymes released into the blood when liver cells are damaged. They are among the most important markers for fatty liver disease, hepatitis, and liver inflammation. [3]
- Normal ALT: 7 to 56 IU/L (men); 7 to 45 IU/L (women)
- Normal AST: 10 to 40 IU/L In fatty liver disease, ALT is typically elevated more than AST. An AST-to-ALT ratio above 2:1 can suggest alcoholic liver disease or more advanced liver damage.
CMP vs Basic Metabolic Panel (BMP): What Is the Difference?
The basic metabolic panel (BMP) is a shorter version of the CMP, containing 8 of the same tests. The CMP adds 6 additional tests, primarily related to liver function.
| Test | Included in BMP | Included in CMP |
|---|---|---|
| Glucose | Yes | Yes |
| BUN / Creatinine / eGFR | Yes | Yes |
| Sodium, Potassium, CO2, Chloride | Yes | Yes |
| Calcium | Yes | Yes |
| Total Protein | No | Yes |
| Albumin | No | Yes |
| Total Bilirubin | No | Yes |
| ALP, ALT, AST (liver enzymes) | No | Yes |
A BMP is ordered when a doctor wants a quick check of kidney function, electrolytes, and blood sugar without needing liver function data. A CMP is ordered when a more comprehensive picture of metabolic health is needed, or when liver disease, fatty liver, or medication-related liver toxicity is a concern.
| Which Should You Get? If you have been diagnosed with fatty liver, metabolic syndrome, diabetes, or are on long-term medications, a CMP gives more useful information than a BMP. For a basic annual check without specific liver concerns, a BMP is sufficient. Your doctor will determine which is appropriate based on your health history. |
|---|
CMP Normal Ranges at a Glance
The following reference ranges are commonly used in clinical practice. Note that normal ranges can vary slightly between laboratories depending on their equipment and calibration standards. Always compare your results against the reference range printed on your specific lab report.
| Test | Normal Range | Elevated May Indicate | Low May Indicate |
|---|---|---|---|
| Glucose (fasting) | 70 to 99 mg/dL | Diabetes, prediabetes, stress | Hypoglycaemia, insulin excess |
| BUN | 7 to 20 mg/dL | Kidney disease, dehydration | Malnutrition, liver disease |
| Creatinine (men) | 0.74 to 1.35 mg/dL | Kidney disease, muscle breakdown | Low muscle mass |
| Creatinine (women) | 0.59 to 1.04 mg/dL | Kidney disease | Low muscle mass |
| eGFR | Above 60 mL/min/1.73m2 | N/A (lower is worse) | Chronic kidney disease |
| Sodium | 136 to 145 mEq/L | Dehydration, excess sodium | Overhydration, kidney issues |
| Potassium | 3.5 to 5.0 mEq/L | Kidney disease, acidosis | Diuretics, malnutrition |
| CO2 (Bicarbonate) | 23 to 29 mEq/L | Metabolic alkalosis | Metabolic acidosis |
| Chloride | 96 to 106 mEq/L | Dehydration | Overhydration, vomiting |
| Calcium | 8.5 to 10.2 mg/dL | Hyperparathyroidism, cancer | Hypoparathyroidism, deficiency |
| Total Protein | 6.3 to 8.2 g/dL | Dehydration, infection | Liver disease, malnutrition |
| Albumin | 3.5 to 5.0 g/dL | Dehydration | Liver disease, malnutrition |
| Total Bilirubin | 0.1 to 1.2 mg/dL | Liver disease, haemolysis | Rarely clinically significant |
| ALP | 44 to 147 IU/L | Liver or bone disease | Malnutrition, hypothyroidism |
| ALT / AST | ALT 7-56, AST 10-40 IU/L | Fatty liver, hepatitis, toxicity | Rarely clinically significant |
How to Prepare for a Comprehensive Metabolic Panel
Proper preparation ensures your results are accurate and comparable across repeat tests.
- Fast for 8 to 12 hours before the test: Water is permitted and encouraged. Black coffee and tea without sugar or milk are generally acceptable, but check with your doctor.
- Do not take your morning medications before the test unless your doctor specifically says to: Some medications can affect glucose, kidney, and liver markers.
- Avoid strenuous exercise the day before: Intense exercise can temporarily elevate AST and creatinine levels, potentially giving a falsely abnormal result.
- Inform the lab about all medications and supplements: Including herbal and Ayurvedic preparations, which can affect liver enzyme readings.
- Schedule the test in the morning: Most reference ranges are established based on morning fasting samples.
| Important: Alcohol consumption in the 24 to 48 hours before a CMP can significantly elevate liver enzymes (ALT, AST, GGT) and bilirubin, leading to misleading results. Avoid alcohol for at least 48 hours before the test. |
|---|
CMP Results and Metabolic Syndrome: What to Watch For
Metabolic syndrome is defined as the presence of three or more of the following five criteria: elevated fasting glucose, elevated blood pressure, elevated triglycerides, reduced HDL cholesterol, and increased waist circumference. [4]
While the CMP does not measure blood pressure, triglycerides, HDL cholesterol, or waist circumference directly, it provides critical supporting information for metabolic syndrome assessment:
- Elevated fasting glucose (100 mg/dL or above): directly meets one of the five criteria for metabolic syndrome diagnosis [1]
- Elevated ALT and AST: strongly associated with non-alcoholic fatty liver disease (NAFLD), which is present in up to 75% of people with metabolic syndrome [3]
- Reduced eGFR or elevated creatinine: indicates kidney involvement, which becomes more common as metabolic syndrome progresses [2]
- Low albumin: can indicate nutritional deficiency or chronic inflammation, both of which are associated with metabolic syndrome For a complete metabolic syndrome assessment, the CMP is typically ordered alongside a lipid profile (to measure triglycerides and HDL) and a blood pressure measurement.
How to Read Your CMP Results
When you receive your CMP report, do not focus on a single abnormal value in isolation. The pattern across all 14 markers is what provides the most meaningful clinical picture. Here are some common patterns to understand:
Pattern 1: Elevated Glucose + Abnormal Liver Enzymes
This combination strongly suggests fatty liver disease with insulin resistance. It is extremely common in India, particularly among people with sedentary lifestyles and high-carbohydrate diets. Your doctor may follow up with an abdominal ultrasound and a full lipid profile.
Pattern 2: Elevated Creatinine + Reduced eGFR + Abnormal Electrolytes
This pattern suggests kidney dysfunction. Causes range from dehydration (in which case values normalise quickly) to chronic kidney disease. Your doctor will likely order a repeat test and a urine test to confirm.
Pattern 3: Elevated Bilirubin + Elevated ALP + Elevated ALT/AST
This triad points to liver disease or bile duct obstruction. Further investigation with an ultrasound and additional liver-specific tests is usually indicated.
Pattern 4: Low Albumin + Low Total Protein
This can indicate malnutrition, liver disease (reduced protein synthesis), or kidney disease (protein leaking into urine). Your doctor will consider your diet, weight history, and other clinical findings.
Track Your Metabolic Health Between CMP Tests with Hint
A CMP gives you a snapshot of your metabolic health at a single point in time, but what you do between tests determines whether your next results improve or worsen. Hint helps you stay on track:
- Monitor fasting blood sugar trends through daily food logging and meal tracking
- Follow Indian diet plans designed to support healthy liver enzymes and kidney function
- Track weight loss progress, which directly impacts glucose, ALT, and AST levels
- Set medication and lab test reminders so you never miss a follow-up CMP
- Access personalised metabolic health plans from certified dietitians (Hint Premium) Download the Hint app from the App Store or Google Play to start tracking your metabolic health today.
Frequently Asked Questions
Do I need to fast for a comprehensive metabolic panel?
Yes, fasting for 8 to 12 hours is recommended before a CMP to ensure accurate glucose and other results. Water is fine to drink. Confirm with your doctor or the lab if you are unsure.
What is the difference between a CMP and an LFT?
A liver function test (LFT) in India typically measures ALT, AST, ALP, bilirubin, albumin, and total protein, which is essentially the liver portion of a CMP. A CMP includes those liver tests plus kidney function (BUN, creatinine, eGFR), electrolytes (sodium, potassium, CO2, chloride), calcium, and blood glucose.
How often should I get a CMP?
For healthy adults with no known conditions, once a year, as part of a routine health check, is generally adequate. For people with diabetes, fatty liver, kidney disease, or metabolic syndrome, your doctor may recommend every 3 to 6 months, depending on how well the condition is controlled.
Can a CMP detect cancer?
A CMP is not a cancer screening test, but it can detect abnormalities that may prompt further investigation. For example, elevated ALP or bilirubin may lead to imaging tests that detect liver tumours. Abnormal CMP results are a starting point for investigation, not a diagnosis.
Can medications affect my CMP results?
Yes. Statins and certain antibiotics can elevate liver enzymes. NSAIDs and some blood pressure medications can affect kidney markers. Metformin can affect kidney function markers in some cases. Always inform your doctor about all medications and supplements before your test.
What if one value is slightly outside the normal range?
A single mildly abnormal value does not necessarily mean there is a problem. Temporary factors like dehydration, recent exercise, or a large meal the day before can affect results. Your doctor will interpret your CMP in the context of your symptoms, health history, and other tests before concluding.
References
- American Diabetes Association Professional Practice Committee. Standards of Medical Care in Diabetes—2023. Diabetes Care. 2023;46(Suppl 1):S1-S291. https://diabetesjournals.org/care/issue/46/Supplement_1
- Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int Suppl. 2013;3:1-150. https://kdigo.org/guidelines/ckd-evaluation-and-management/
- Kwo PY, Cohen SM, Lim JK. ACG Clinical Guideline: Evaluation of Abnormal Liver Chemistries. Am J Gastroenterol. 2017;112(1):18-35. PubMed: https://pubmed.ncbi.nlm.nih.gov/27995906/
- Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention. Circulation. 2009;120(16):1640-1645. PubMed: https://pubmed.ncbi.nlm.nih.gov/19805654/
- Younossi ZM, Koenig AB, Abdelatif D, Fazel Y, Henry L, Wymer M. Global epidemiology of nonalcoholic fatty liver disease: meta-analytic assessment of prevalence, incidence, and outcomes. Hepatology. 2016;64(1):73-84. PubMed: https://pubmed.ncbi.nlm.nih.gov/26707365/
About the Author
Dr. Sumedha Verma is a Consultant Physician at Clearcals with extensive experience in clinical medicine and healthcare services.
She has significant expertise in managing chronic conditions such as fatty liver, diabetes, thyroid disorders, PCOS, infertility, and other gynecological health concerns.
Known for her patient-centered approach, Dr. Verma focuses on improving patient compliance and helping individuals achieve better health outcomes through personalized medical guidance and long-term care.
🔗 Connect with Dr. Sumedha on LinkedIn
